Bolsas y Mercados Argentinos SA (BYMA)
Buenos Aires Exchange · Argentina · prices in ARS · close of 22 Oct 2026
Key indicators
| Last close | ARS 242.75 |
|---|---|
| 52-week range | 177.50 – 351.75 |
| Return, 1 month / 3 months | −7.0% / −17.9% |
| Return, 1 year / 3 years | +32.7% / −65.4% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 36.3% |
| Worst drawdown (1 year) | -32.2% |
| Average daily value traded | 1,016.82M ARS |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bolsas y Mercados Argentinos, known as BYMA, operates the main securities market infrastructure in Argentina and is based in Buenos Aires. It runs the trading platform where equities, corporate and government bonds, and other instruments change hands, and it provides the clearing, settlement and depositary services that support those trades. Its customers are brokers, institutional investors, issuers and other market participants who rely on its systems to execute and process transactions in the Argentine market.
The shares are listed on the Buenos Aires Exchange in Argentina under the code BYMA, and the price on this page is in Argentine pesos (ARS). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bolsas y Mercados Argentinos SA (BYMA) trades on the Buenos Aires Exchange in Argentina. It last closed at ARS 242.75 on 22 October 2026.
Its price-based Market X-Ray is 45 out of 100 (a weak price profile), ranking 96 of 154 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 32.7% and over the last three months it fell 17.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Buenos Aires Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.9% | ||
| From 52-week high | -29.9% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.9% | ||
| 6-month return | -24.2% | ||
| 12-month return, skipping the last month | 42.6% | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 36.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -32.2% | ||
| Liquidity | 80 · Strong | Trades actively. | |
| Average daily value traded | 1,016.82M ARS | ||
| Zero-volume days | 1.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 1 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −5.6% |
|---|---|
| 1 month | −7.0% |
| 3 months | −17.9% |
| 6 months | −24.2% |
| 1 year | +32.7% |
| 3 years | −65.4% |
| 5 years | +212.2% |
Signals
| 50-day / 200-day average | 258.24 / 295.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Apr 2022 | ARS 22.7573 |
| 29 Apr 2021 | ARS 6.7039 |
| 20 Mar 2020 | ARS 2.6951 |
| 15 Apr 2019 | ARS 5.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Buenos Aires Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.